[1]张斌斌,王湘琦,赵超然,等. 阻断PI3K/AKT/mTOR通路增强顺铂诱导的人皮肤黑素瘤细胞株A375凋亡的机制研究[J].中国美容医学,2019,(08):72-76.
 ZHANG Bin-bin,WANG Xiang-qi,ZHAO Chao-ran,et al. The Mechanism of Blocking PI3K/AKT/mTOR Pathway Enhances Cisplatin-inducedHuman Skin Melanoma Cell Line A375 Apoptosis[J].Medical Aesthetics and Beauty,2019,(08):72-76.
点击复制

 阻断PI3K/AKT/mTOR通路增强顺铂诱导的人皮肤黑素瘤细胞株A375凋亡的机制研究
()
分享到:

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2019年08期
页码:
72-76
栏目:
出版日期:
2019-08-05

文章信息/Info

Title:
 The Mechanism of Blocking PI3K/AKT/mTOR Pathway Enhances Cisplatin-induced
Human Skin Melanoma Cell Line A375 Apoptosis
文章编号:
1008-6455(2019)08-0072-05
作者:
张斌斌王湘琦赵超然熊爱兵
Author(s):
 ZHANG Bin-binWANG Xiang-qiZHAO Chao-ranXIONG Ai-bing
关键词:
[关键词]PI3K/AKT/mTORBcl-2黑素瘤细胞A375顺铂凋亡
Keywords:
Key words: PI3K/AKT/mTOR Bcl-2 melanoma cells A375 cisplatin apoptosis
分类号:
R732.2
文献标志码:
A
摘要:
[摘要]目的:本实验探讨抑制PI3K/AKT/mTOR通路对顺铂诱导人皮肤黑素瘤细胞株A375细胞凋亡作用及其机制。方法:用顺
铂处理人皮肤黑素瘤细胞株A375细胞后Western blot检测细胞凋亡、PI3K/AKT/mTOR通路的活化情况以及细胞增殖-毒性检测
试剂盒(Cell Counting Kit-8,CCK-8)。用PI3K的抑制剂LY294002(LY)和mTOR的抑制剂雷帕霉素(Rapamycin,Rap)分
别预处理以研究其对顺铂处理后人皮肤黑素瘤细胞株A375细胞凋亡的协同作用。为进一步探索阻断PI3K/AKT/mTOR通路对顺
铂处理后人皮肤黑素瘤细胞株A375细胞凋亡的协同作用机制,采用Western blot检测阻断PI3K/AKT/mTOR后联用顺铂处理人
皮肤黑素瘤细胞株A375细胞中Bcl-2、Bcl-xl蛋白表达。结果:顺铂处理后的A375黑素瘤细胞中PARP的活化剪切体表达量水
平呈浓度和时间依赖性增加,细胞活力呈浓度和时间依赖性降低(P <0.05)。顺铂处理A375黑素瘤细胞后PI3K/AKT/mTOR通
路的活化。阻断PI3K/AKT/mTOR通路再用顺铂联合处理A375黑素瘤细胞后PARP的活化剪切体表达量明显上调以及细胞活力明
显降低(P <0.05)。阻断PI3K/AKT/mTOR通路后再用顺铂联合处理A375黑素瘤细胞发现Bcl-2蛋白和Bcl-xl表达水平下调。
结论:阻断PI3K/AKT/mTOR通路对顺铂诱导的细胞凋亡具有协同作用,该协同作用可能与Bcl-2和Bcl-xl蛋白下调有关。

Abstract:
Abstract: Objective This study was designed to investigate the effects and mechanisms of inhibiting PI3K/AKT/mTOR
pathway on cisplatin-induced human skin melanoma cell line A375 apoptosis. Methods Western blot analyses were used to
detect apoptosis and activation of PI3K/AKT/mTOR pathway, CCK-8 was used to detect cell viability in human skin melanoma
cell line A375 treated with cisplatin. The synergistic effects of PI3K inhibitor LY294002 (LY) and mTOR inhibitor Rapamycin
(Rap) on cisplatin human skin melanoma cell line A375 apoptosis were investigated.To further explore the synergistic
mechanism of blocking PI3K/AKT/mTOR pathway in cisplatin-induced human skin melanoma cell line A375 apoptosis,
Western blot analyses were used to detect Bcl-2 protein expression of blocking PI3K/AKT/mTOR Pathway in human skin
melanoma cell line A375. Results The expression level of PARP activated-cleavage increased in a concentration-and timedependent
manner in A375 melanoma cells cisplatin treatment.Cell viability decreased in a concentration and time-dependent
manner(P <0.05). Activation of the PI3K/AKT/mTOR pathway following treatment of A375 melanoma cells with cisplatin.
After blocking PI3K/AKT/mTOR pathway combined with cisplatin in A375 melanoma cells , the expression of PARP activatedcleavage
increased significantly and cell viability decreased significantly(P <0.05). Bcl-2 protein and Bcl-xl protein expression
was down-regulated after blocking PI3K/AKT/mTOR pathway combined with cisplatin in A375 melanoma cells. Conclusion
Blocking PI3K/AKT/mTOR pathway has synergistic effect in cisplatin-induced apoptosis, it may be related to the down
regulation of Bcl-2 protein and Bcl-xl protein.

相似文献/References:

[1]蒋朝龙,史高峰,李 虎,等. 甲基莲心碱对增生性瘢痕成纤维细胞Bcl-2、Bax及Caspase-3表达影响的研究[J].中国美容医学,2018,(03):108.
 JIANG Zhao-long,SHI Gao-feng,LI Hu,et al. Research of Influence of Neferine on Expression of Bcl-2, Bax and Caspase-3 in Hypertrophic Scar Fibroblast[J].Medical Aesthetics and Beauty,2018,(08):108.
[2]马 旭,杨大平,刘国锋,等. 脂肪干细胞抑制UVB诱导的细胞外基质降解的机制研究[J].中国美容医学,2019,(06):67.
 MA Xu,YANG Da-ping,LIU Guo-feng,et al.The Mechanism of Adipose Derived Stem Cells Inhibiting UVB-induced Extracellular Matrix Degradation[J].Medical Aesthetics and Beauty,2019,(08):67.
[3]张馨予,马 肃,丰靖馨,等.丹参酮ⅡA对鼠环孢素性牙龈增生及Bcl-2阳性表达影响的研究[J].中国美容医学,2022,(6):84.
 ZHANG Xinyu,MA Su,FENG Jingxin,et al.Study on Infl uence of Tan A on Murine Cyclosporine Gingival Hyperplasia and Positive Expression of Bcl-2[J].Medical Aesthetics and Beauty,2022,(08):84.

更新日期/Last Update: 2019-08-29